Ογκολογία Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study Authors: Barbara Burtness et al. 23/11/2019 time to read 3 min read